Strategic Plan Question Detail
Interagency Autism Coordinating Committee (IACC) logo
Office of Autism Research Coordination (OARC) logo

Question 4: Which Treatments And Interventions Will Help? (Treatments)  

$68,123,890.33
Fiscal Year: 2010

Download 2010 Question 4 projects (EXCEL)
Note: Initial Sort is by Principal Investigator. Sorting by other columns is available by clicking on the desired column header.
Project Title Principal Investigator Strategic Plan Objective Institution
Animal models of autism: Pathogenesis and treatment Powell, Craig Q4.S.B University of Texas Southwestern Medical Center
Novel genetic animal models of autism Powell, Craig Q4.S.B University of Texas Southwestern Medical Center
Neuroligin function in vivo: Implications for autism and mental retardation Powell, Craig Q4.S.B University of Texas Southwestern Medical Center
The comparison of three behavioral therapy approaches for children with autism Quinn, Sheila Q4.S.F University of Rhode Island
Genetic models of serotonin transporter regulation linked to mental disorders Ramamoorthy, Sammanda Q4.S.B Medical University of South Carolina
Altering motivational variables to treat stereotyped behavior Rapp, John Q4.Other St. Cloud State University
Cognitive-behavioral group treatment for anxiety symptoms in adolescents with high-functioning autism spectrum disorders Reaven, Judy Q4.S.A University of Colorado Denver
Training outpatient clinicians to deliver cognitive behavior therapy to children Reaven, Judy Q4.S.C University of Colorado Denver
Role of a novel Wnt pathway in autism spectrum disorders Reichardt, Louis Q4.S.B University of California, San Francisco
Association of cholinergic system dysfunction with autistic behavior in fragile X syndrome: Pharmacologic and imaging probes Reiss, Allan Q4.L.A Stanford University
A novel cell-based assay for autism research and drug discovery Restifo, Linda Q4.S.B University of Arizona
Caspr2 dysfunction in autism spectrum disorders Robbins, Elissa Q4.S.B Yale University
Design & synthesis of novel CNS-active oxytocin and vasopressin receptor ligands Roberts, Edward Q4.Other The Scripps Research Institute
ACE Network: A multi-site randomized study of intensive treatment for toddlers with autism Rogers, Sally Q4.S.D University of California, Davis
Intervention for infants at risk for autism Rogers, Sally Q4.S.D University of California, Davis
Initial investigation of prevention of ASD in infants at risk Rogers, Sally; Vismara, Laurie Q4.L.B University of California, Davis
Novel strategies to manipulate Ube3a expression for the treatment of autism and Angelman syndrome Roth, Bryan Q4.S.B University of North Carolina at Chapel Hill
Hy Weinberg Center for Communication Disorders Sabbague, Mireille Q4.S.G Adelphi University
Randomized phase 2 trial of RAD001 (an MTOR inhibitor) in patients with tuberous sclerosis complex Sahin, Mustafa Q4.L.A Childrens Hospital Boston
A novel adaptive transactional virtual reality-based assistive technology for autism intervention Sarkar, Nilanjan Q4.Other Vanderbilt University
1/5-Randomized trial of parent training for young children with autism Scahill, Lawrence Q4.S.D Yale University
4/4-RUPP Autism Network: Guanfacine for the treatment of hyperactivity in PDD Scahill, Lawrence Q4.L.C Yale University
Effectiveness of sensory based strategies for improving adaptive behaviors in children with autism Schaaf, Roseann Q4.S.C Thomas Jefferson University
Methods for production of ICSI and SCNT derived macaque stem cells Schatten, Gerald Q4.S.B Southwest Foundation For Biomedical Research
Optimization of methods for production of both ICSI- and SCNT derived baboon embryonic stem cells Schatten, Gerald Q4.S.B Southwest Foundation For Biomedical Research